Vaccine Contract Manufacturing Market is expected to grow at a CAGR of 9.3% from 2014 to 20252/27/2018 The global vaccine contract manufacturing market size is expected to reach USD 4.0 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a 9.3% CAGR during the forecast period. The market is anticipated to witness significant growth over the coming years thanks to rising demand for vaccine development from the private sector as well as governments in industrialized and developing countries. Vaccine contract services offer cost-saving benefits to their clients. They also help save time in operations and management of a production and research facility. These advantages associated with Contract Manufacturing Organizations (CMOs) are expected to benefit emerging players, start-ups, and small players who lack adequate facilities and resources required for vaccine development. Increase in pricing pressure, regulatory challenges, and patent expiration in recent times are expected to adversely impact the market. Contract services are considered “strategic competitive weapons” among vaccine manufacturers as they help overcome the aforementioned issues. A number of international healthcare organizations are engaged in estimating and predicting the quantity of goods as well as financial need required for conducting immunization programs. Some of the factors considered for this estimation are quantity of vaccines, estimated time of delivery, product type, and vial size. Participation of international healthcare organizations in vaccination programs is expected to positively influence the growth of contract manufacturers. Full Research Report On Global Vaccine Contract Manufacturing Market By Grand View Research: www.grandviewresearch.com/industry-analysis/vaccine-contract-manufacturing-market Further key findings from the report suggest:
www.grandviewresearch.com/industry/pharmaceuticals Grand View Research has segmented the global vaccine contract manufacturing market on the basis of vaccine type, workflow, application, and region: Vaccine Contract Manufacturing Vaccine Type Outlook (Revenue, USD Million, 2014 - 2025)
www.grandviewresearch.com/press-release/global-vaccine-contract-manufacturing-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. For More Information: www.grandviewresearch.com
0 Comments
Leave a Reply. |